One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25 years. Among older people with diabetes, 30-45% are affected by frailty (Frailty) The risk of frailty increases with increasing HbA1c. The incidence of atherosclerotic cardiovascular disease (ASCVD) doubles with age, with a prevalence of 38.5% for coronary heart disease (CHD), 13% for stroke and 12% for peripheral arterial disease (PAD) in people aged ≥70 years. In addition to their glucose-controlling effect, new antidiabetic drugs have organ-protective benefits and have brought about a paradigm shift in diabetology.
Autoren
- Dr. med. Young Hee Lee-Barkey
- PD Dr. rer. nat. Bernd Stratmann
- Prof. Dr. med. Susanne Reger-Tan
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Sarcoidosis, echinococcosis & Co.
Suspected symptoms and differential diagnoses
- Cancer prevention
Constant dripping – alcohol and cancer
- Steatotic liver disease
GLP-1RA in MASH – what’s new?
- Chronic pruritus: “Tour d'horizon”
Focus on new anti-inflammatory therapeutic approaches
- Multiple sclerosis
Unexpected side effects when switching from natalizumab to a biosimilar
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Immunotherapy
Subcutaneously or intravenously?
- Work-related asthma